In the inaugural episode, we explore the origins of BioLineRx and its transformation from a biotech incubator to a fully-fledged biotech company. Joined by Phil Serlin, CEO of BioLineRx, we uncover the company's early days, its broad pipeline spanning various therapeutic areas, and the strategic decision-making process that led to its evolution. From strategic evaluations to pivoting towards oncology and hematology, this episode highlights the importance of persistence and strategic adaptability in the biotech industry.

Ver todos los episodios